Emergent Technologies for Cardiovascular Surgery  

作　　者：GUIDOIN Robert 于成龙 李超婧 NUTLEY Mark 林婧 张泽 王璐 DOUVILLE Yvan 

机构地区：[1]Department of Surgery,Laval University and Axe Regenerative Medicine,Research Centre CHU [2]Key Laboratory of Textile Science and Technology of Ministry of Education and College of Textile,Donghua University [3]Peter Lougheed Centre,University of Calgary

出　　处：《Journal of Donghua University(English Edition)》2017年第2期325-332,共8页东华大学学报（英文版）

基　　金："111 Project" Biomedical Textile Material Science and Technology,China(No.B07024);National Natural Science Foundations of China(Nos.31100682,81371648);the Shanghai Construction of College Experiment Technique Team Project,China(No.101-07.0053014);the Fundamental Research Funds for the Central University,China(No.15D110126);the Department of Surgery at Laval University,Quebec and the Fonds de Recherche en Chirurgie Vasculaire of the CHU,Quebec,Canada

摘　　要：The optimal vascular blood supply throughout the body guarantees the support of normal functions to tissues and organs.Implants are now becoming a seamless extension of the body and shall accompany a higher level of fidelity between the device and the patient.As regenerative medicine is still in its infancy,the ongoing search for new and effective prosthetic alternatives continues to be essential and highly rewarding.Thanks in part to the progress of imaging and the benefits of 3D printing,previously unimagined emergent technologies are at hand.The emerging technologies of the last few decades and the near future will continue to greatly improve both the quality and quantity of patients' lives.They focus on minimally invasive technologies(keyhole surgery) and approaches for deployment of valves,stent-grafts,leadless pacemakers and adaptation of medical devices for destination therapy(assist devices and artificial hearts).In addition,specific blood conduits for the aortic valves together with the aortic arch and the pulmonary valves are considered.These breakthroughs are currently at various stages of development and acceptability.Innovative biomaterials were essential in the development of cardiovascular devices.They were and they still are the essential support for conduction prosthesis,but their place in signal prosthesis is being revisited.Any new development in medical devices has been frequently driven by surgeons and industry.The emergent technologies are introduced by pioneers.The risks and benefits of devices must be continuously reassessed during the lifetime of the implants based upon sound scientific principles of investigation,clinical experience of the users and retrieval programs.The optimal vascular blood supply throughout the body guarantees the support of normal functions to tissues and organs.Implants are now becoming a seamless extension of the body and shall accompany a higher level of fidelity between the device and the patient.As regenerative medicine is still in its infancy,the ongoing search for new and effective prosthetic alternatives continues to be essential and highly rewarding.Thanks in part to the progress of imaging and the benefits of 3D printing,previously unimagined emergent technologies are at hand.The emerging technologies of the last few decades and the near future will continue to greatly improve both the quality and quantity of patients＇ lives.They focus on minimally invasive technologies（keyhole surgery） and approaches for deployment of valves,stent-grafts,leadless pacemakers and adaptation of medical devices for destination therapy（assist devices and artificial hearts）.In addition,specific blood conduits for the aortic valves together with the aortic arch and the pulmonary valves are considered.These breakthroughs are currently at various stages of development and acceptability.Innovative biomaterials were essential in the development of cardiovascular devices.They were and they still are the essential support for conduction prosthesis,but their place in signal prosthesis is being revisited.Any new development in medical devices has been frequently driven by surgeons and industry.The emergent technologies are introduced by pioneers.The risks and benefits of devices must be continuously reassessed during the lifetime of the implants based upon sound scientific principles of investigation,clinical experience of the users and retrieval programs.

关 键 词：heart valve stent graft right ventricular outflow tract(RVOT) percutaneous valve leadless pacemakers cardiovascular emergent technologies 

分 类 号：R318.11[医药卫生—生物医学工程]